128 related articles for article (PubMed ID: 36562254)
1. Impaired adaptive immune response in COVID-19 convalescent patients with hematological malignancies.
Kalicińska E; Szymczak D; Andrasiak I; Milanowska A; Kiraga A; Majeranowski A; Jabłonowska P; Rybka J; Maciej Z; Wróbel T
Eur J Haematol; 2023 Apr; 110(4):396-406. PubMed ID: 36562254
[TBL] [Abstract][Full Text] [Related]
2. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
3. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal SARS-CoV-2-specific CD8
Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
[TBL] [Abstract][Full Text] [Related]
5. Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.
Kudryavtsev IV; Arsentieva NA; Korobova ZR; Isakov DV; Rubinstein AA; Batsunov OK; Khamitova IV; Kuznetsova RN; Savin TV; Akisheva TV; Stanevich OV; Lebedeva AA; Vorobyov EA; Vorobyova SV; Kulikov AN; Sharapova MA; Pevtsov DE; Totolian AA
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146713
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study.
Kalicińska E; Szymczak D; Andrasiak I; Bogucka-Fedorczuk A; Zińczuk A; Szymański W; Biernat M; Rymko M; Semeńczuk G; Jabłonowska P; Rybka J; Simon K; Wróbel T
Transl Oncol; 2021 Jan; 14(1):100943. PubMed ID: 33204385
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
Front Immunol; 2022; 13():886431. PubMed ID: 35757700
[TBL] [Abstract][Full Text] [Related]
8. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
Kalicińska E; Szymczak D; Zińczuk A; Adamik B; Smiechowicz J; Skalec T; Nowicka-Suszko D; Biernat M; Bogucka-Fedorczuk A; Rybka J; Martuszewski A; Gozdzik W; Simon K; Wróbel T
Cells; 2021 May; 10(6):. PubMed ID: 34071149
[TBL] [Abstract][Full Text] [Related]
10. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte Phenotyping and HLA-DR Expression over the Course of COVID-19 Infection in Patients with Different Disease Severity.
Asmaa-Nafady ; Alaa-Rashad ; Nafady-Hego H; Nasif KA; Ebtessam-Elgezawy ; Elrahman NA; Osman HA
Clin Lab; 2022 May; 68(5):. PubMed ID: 35536080
[TBL] [Abstract][Full Text] [Related]
12. Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.
Torres Rives B; Zúñiga Rosales Y; Mataran Valdés M; Roblejo Balbuena H; Martínez Téllez G; Rodríguez Pérez J; Caridad Marín Padrón L; Rodríguez Pelier C; Sotomayor Lugo F; Valdés Zayas A; Carmenate Portilla T; Sánchez Ramírez B; Carlos Silva Aycaguer L; Portal Miranda JA; Marcheco Teruel B
Immunobiology; 2022 May; 227(3):152216. PubMed ID: 35436751
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
Liu J; Yang X; Wang H; Li Z; Deng H; Liu J; Xiong S; He J; Feng X; Guo C; Wang W; Zelinskyy G; Trilling M; Sutter K; Senff T; Menne C; Timm J; Zhang Y; Deng F; Lu Y; Wu J; Lu M; Yang D; Dittmer U; Wang B; Zheng X
mBio; 2021 Apr; 12(2):. PubMed ID: 33906918
[TBL] [Abstract][Full Text] [Related]
14. Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine.
Al-Attiyah R; Safar HA; Botras L; Botras M; Al-Kandari F; Chehadeh W; Mustafa AS
Front Immunol; 2022; 13():851765. PubMed ID: 35898494
[TBL] [Abstract][Full Text] [Related]
15. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
[TBL] [Abstract][Full Text] [Related]
16. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
[TBL] [Abstract][Full Text] [Related]
17. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
[TBL] [Abstract][Full Text] [Related]
18. Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.
Bagchi AK; Sinha AK; Adhikari R; Mukherjee J
Mol Cell Biochem; 2010 May; 338(1-2):1-10. PubMed ID: 19915959
[TBL] [Abstract][Full Text] [Related]
19. [Lymphocyte populations and subpopulations in peripheral blood of pregnant women with pre-eclampsia].
Dimitrakova-Dzhambazova E; Milchev N; Pavlov P; Dimitrakov D
Akush Ginekol (Sofiia); 2005; 44(1):40-4. PubMed ID: 15853011
[TBL] [Abstract][Full Text] [Related]
20. Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome.
Bobcakova A; Petriskova J; Vysehradsky R; Kocan I; Kapustova L; Barnova M; Diamant Z; Jesenak M
Front Cell Infect Microbiol; 2021; 11():646688. PubMed ID: 33937096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
